Pterostilbene attenuates cisplatin-induced acute kidney injury by suppressing TLR4/MyD88/NF-κB signaling.
Findings indicate that PTE protects against Cis-AKI, at least in part, through suppression of the TLR4/MyD88/NF-κB signaling cascade, thereby mitigating inflammation, oxidative stress, and apoptosis.